VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 119 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $431 | -52.4% | 46,000 | +24.7% | 0.00% | -50.0% |
| Q2 2023 | $905 | -63.3% | 36,900 | -65.2% | 0.00% | 0.0% |
| Q1 2023 | $2,463 | +183.8% | 105,900 | +208.7% | 0.00% | 0.0% |
| Q4 2022 | $868 | -99.9% | 34,300 | -21.3% | 0.00% | 0.0% |
| Q3 2022 | $840,000 | +8.9% | 43,600 | +43.9% | 0.00% | +33.3% |
| Q2 2022 | $771,000 | +15.8% | 30,300 | +17.0% | 0.00% | +50.0% |
| Q1 2022 | $666,000 | -23.1% | 25,900 | +25.1% | 0.00% | -33.3% |
| Q4 2021 | $866,000 | +2.1% | 20,700 | +6.2% | 0.00% | 0.0% |
| Q3 2021 | $848,000 | +52.2% | 19,500 | +65.3% | 0.00% | +50.0% |
| Q2 2021 | $557,000 | -7.8% | 11,800 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $604,000 | +91.1% | 11,800 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $316,000 | -44.2% | 11,800 | -28.5% | 0.00% | -50.0% |
| Q3 2020 | $566,000 | +183.0% | 16,500 | +236.7% | 0.00% | +100.0% |
| Q2 2020 | $200,000 | +207.7% | 4,900 | +157.9% | 0.00% | – |
| Q1 2020 | $65,000 | +182.6% | 1,900 | 0.0% | 0.00% | – |
| Q4 2019 | $23,000 | – | 1,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |